Prudential Financial »

Compass Therapeutics shares owned by Prudential Financial

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Prudential Financial from 13F filings

Historical chart of Prudential Financial investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Prudential Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Prudential Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.7M 315k 5.37

More positions owned by Prudential Financial

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Us Equity Marke (DFUS)
Pgim Etf Tr Aaa Clo Etf (PAAA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Pgim Etf Tr Pgim Ultra Sh B (PULS)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)

View all positions for Prudential Financial

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
Blackstone Group
Vivo Capital
BlackRock
Vanguard Group
Enavate Sciences GP
Adage Capital Partners GP
State Street Corporation
BVF
FMR
Rock Springs Capital Management
Deerfield Management Company
Geode Capital Management

View all funds holding Compass Therapeutics